TC與GP方案治療晚期肺鱗狀細胞癌臨牀療效觀察對比

...words】squamouscellcarcinomaofthelung;combinedchemotherapy；paclitaxel；carboplatin；gemcitabine；cisplatin肺癌發病率與死亡率爲全球首位，其中非小細胞肺癌佔肺癌75%～80%,大多數患者已處於中晚期階段,以化療爲主的綜合治療在晚期非小細胞肺癌治...

雙途徑聯合化療治療晚期非小細胞肺癌的臨牀觀察

...afterthepleuraleffusionwasdrainedout,andintravenousinjectionofpaclitaxelandcarboplatin(TC)wereadministeredonday2,thiscombinedregimenwasrepeatedeverythreeweeks.Allpatientsreceivedatleasttwocyclesofthetreatment.ResultsThirty-eightpatientswereenrolled.Allpatientswereincludedinthetoxicityandefficacyanal...

歐洲積極推薦Avastin（R）作爲晚期肺癌患者的一線治療藥物

...的阿瓦斯丁進行治療並配合紫杉醇（paclitaxel）和卡鉑（carboplatin）治療的患者的整體存活期延長了25%。副作用通常是可以控制的。所有進行阿瓦斯丁治療並配合化療的患者中，出現肺出血（咳血）的病例佔2.3%。阿瓦斯丁療法最...

膽囊癌對化療藥物敏感性的研究

...eywere(fromhightolow):cisplatin(DDP)34.77±3.53,mitomycinC(MMC)33.25±3.40,carboplatin(CDB)15.73±4.50,adriamycin(ADM)15.25±3.56,methotrexate(MTX)14.5±2.13,vincristine(VCR)8.5±1.95.ConclusionDDPandMMCaremorechemosensitivethanCDB,ADMandMTXespeciallythanVCR.　　【Keywords】gallbladdercarcinoma;...

數據證實了ALIMTA(R)（注射用培美曲塞）對惡性胸膜間皮瘤患者的療效

...行治療，而其他兩組則通過將ALIMTA與順鉑(cisplatin)或卡鉑(Carboplatin)聯合使用而對ALIMTA進行評估。三組研究在臨牀上顯示了相似的一年期存活率（單獨使用ALIMTA爲58.6%；與順鉑聯合使用爲63.1%；與卡鉑聯合使用爲64.0%）。ALIMTA加鉑聯...

TC和MVP治療晚期非小細胞肺癌前瞻隨機研究

...dvancedNSCLCwererandomizedintotwogroups:TCgroup(n=34,paclitaxel175mg/m2,d1;carboplatin300mg/m2,d2)andMVPgroup(n=34,mitomycinC6-8mg/m2,d1;vindesine2-3mg/m2d1andd8;cisplatin70-80mg/m2,d1andd2).Allpatientsreceivedtwotofourcoursesofchemotherapy.ResultsTheoverallresponsewas62%(21/34)inTCgroupand26%(9/34)...

順鉑誘導胰腺癌細胞凋亡抑制蛋白Survivin表達的實驗研究

...用的化療藥物有：順鉑(cisplation,DDP)、紫杉醇(taxol)、卡鉑(carboplatin)、氟尿嘧啶(5-fluorouracil,5-Fu)、長春新鹼(vineristin)、絲裂黴素(mitomycin,MMC)等［1］。其中順鉑是美國癌症研究所建議的首選藥物，但對順鉑作用機制的研究較少［2］...

TC方案和PAC方案用於上皮性卵巢癌術後化療比較

...mparetheshort-termcurativeeffectsandthesideeffectsbetweenTC（Paclitaxˉel+Carboplatin）andPACchemotherapeuticregimesintreatingepithelialovariancanceraftersurgery.MethodsAretrospectivestudywasperformedon52patientswithepithelialovariancancerwhowerehospitalizedinNanfanghospiˉtalbetweenJan.1999andJan...

胸腔內注入卡鉑和斯奇康治療惡性胸腔積液的臨牀觀察

...apyofpolysaccharidenucleicacidfractionofbacilleCalmette-Guerin(BCG-PSN)pluscarboplatininthetreatmentofmalignantpleuraleffusion.Methods41patientswererandomlyenrolledintotrialandcontrolgroups，21patientsweretreatedwithBCG-PSN(10ml)pluscarboplatin(500mg)weeklyfor2～4timesinthetrialgroup.Twentypatient...

鹽酸吉西他濱與卡鉑聯合香菇多糖治療晚期非小細胞肺癌的臨牀研究

...Clinicalstudyoftreatingadvancednon-smallcelllungcancerwithgemcitabinepluscarboplatincombinelentinan　　WeiQihong，DingHuizhen　　RespiratoryDepartment，YangzhouFirstPeople‘sHospital，Jiangsu225001.　　【Abstract】ObjectiveThemaingoalofourstudyistoevaluatetheefficacyofgemcitabinepluscarb...